Detalhe da pesquisa
1.
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
Ann Neurol
; 93(6): 1053-1068, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866852
2.
Epidemiological and clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in a nationwide survey.
Mult Scler
; 29(4-5): 530-539, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905136
3.
Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Tohoku J Exp Med
; 260(3): 215-221, 2023 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081618
4.
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
N Engl J Med
; 381(7): 614-625, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050279
5.
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Ann Neurol
; 89(6): 1088-1098, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586143
6.
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension.
Mult Scler
; 28(3): 480-486, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498507
7.
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.
Brain
; 144(8): 2401-2415, 2021 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711152
8.
A case of ischemic stroke accompanied by multiple arterial dissections associated with Klippel-Feil syndrome.
J Stroke Cerebrovasc Dis
; 31(5): 106399, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228024
9.
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Brain
; 143(5): 1431-1446, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32412053
10.
Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy.
Neurol Sci
; 42(3): 1135-1138, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078247
11.
CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD.
J Neurol Neurosurg Psychiatry
; 91(6): 605-611, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217788
12.
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.
Brain
; 142(5): 1310-1323, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938427
13.
Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.
Acta Neuropathol
; 137(3): 467-485, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30564980
14.
Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
J Neuroinflammation
; 15(1): 114, 2018 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29673365
15.
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
J Neurol Neurosurg Psychiatry
; 89(9): 927-936, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875186
16.
Efficiency of antibody therapy in demyelinating diseases.
Int Immunol
; 29(7): 327-335, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910968
17.
Abnormal Osmolality Gap Exists in Distal Symmetric Polyneuropathy.
Tohoku J Exp Med
; 246(1): 59-64, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30270254
18.
Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report.
BMC Neurol
; 17(1): 76, 2017 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420330
19.
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
Mult Scler
; 22(11): 1413-1420, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25921053
20.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
Ann Neurol
; 76(2): 305-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24977390